300
Participants
Start Date
November 30, 2004
Primary Completion Date
February 28, 2006
Study Completion Date
February 28, 2006
Synthetic Conjugated estrogens, B
1 (0.3mg) tablet daily
Placebo
1 tablet daily
Duramed Investigational Site, Pittsburgh
Duramed Investigational Site, Laurel
Duramed Investigational Site, Norfolk
Duramed Investigational Site, Newport News
Duramed Investigational Site, Winston-Salem
Duramed Investigational Site, Columbia
Duramed Investigational Site, Alpharetta
Duramed Investigational Site, Gainesville
Duramed Investigational Site, Miami
Duramed Investigational Site, Miami
Duramed Investigational Site, Sarasota
Duramed Investigational Site, Venice
Duramed Investigational Site, Huntsville
Duramed Investigational Site, Clarksville
Duramed Investigational Site, Memphis
Duramed Investigational Site, Columbus
Duramed Investigational Site, Cleveland
Duramed Investigational Site, Mayfield Heights
Duramed Investigational Site, Evansville
Duramed Investigational Site, Billings
Duramed Investigational Site, Baton Rouge
Duramed Investigational Site, Oklahoma City
Duramed Investigational Site, Fort Worth
Duramed Investigational Site, Sugarland
Duramed Investigational Site, San Antonio
Duramed Investigational Site, Denver
Duramed Investigational Site, Colorado Springs
Duramed Investigational Site, Boise
Duramed Investigational Site, Tucson
Duramed Investigational Site, Las Vegas
Duramed Investigational Site, Las Vegas
Duramed Investigational Site, Las Vegas
Duramed Investigational Site, San Diego
Duramed Investigational Site, San Diego
Duramed Investigational Site, Carmichael
Duramed Investigational Site, Medford
Duramed Investigational Site, Tacoma
Duramed Investigational Site, Spokane
Lead Sponsor
Duramed Research
INDUSTRY